Pacific Bioengineering Private Limited

Pacific Bioengineering Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
CIN U74999DL2018PTC342991 Incorporated 13 December 2018 ROC Delhi HQ Delhi, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2024
₹4.51 Cr
▼ 22% YoY
Net profit · FY 2024
₹2.88 Lakh
Net margin 0.6%
EBITDA · FY 2024
₹3.93 Lakh
EBITDA margin 0.9%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings
Active GSTINs
1
of 2 registered

About Pacific Bioengineering Private Limited

Data last updated:

Pacific Bioengineering Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 13 December 2018 and has been in existence for over 8 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2018PTC342991. Its GSTIN is 19AAKCP2473R1ZI (West Bengal). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Vikash Kumar and Sanjib Kumar Rout.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Unit No. 1 Ground Floor Wegmans Prinston Plaza Csc Sector – 18, Rohini, Delhi, India – 110085.

As per the financials filed for FY 2024, the company reported a revenue of ₹4.51 Cr, a decline of 22% compared to the previous year. For the same year it recorded a net profit of ₹2.88 Lakh (net margin 0.6%) and EBITDA of ₹3.93 Lakh (EBITDA margin 0.9%).

Court records list 1 case involving the company, including 1 filed against it; 1 case is pending.

Company Details of Pacific Bioengineering Private Limited
CIN U74999DL2018PTC342991
Registration Number 342991
Incorporation Date 13 December 2018
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Key People
Vikash Kumar Director Sanjib Kumar Rout Director
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    Unit No. 1 Ground Floor Wegmans Prinston Plaza Csc Sector – 18, Rohini, Delhi, India – 110085
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Pacific Bioengineering Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Pacific Bioengineering Private Limited report

Financials, compliance, directors, charges, ownership and filings for Pacific Bioengineering Private Limited in one report.

Financials from FY 2019 Directors & ownership Charges & compliance

Business Activity of Pacific Bioengineering Private Limited

The main business activity of Pacific Bioengineering is trade. In detail, this covers wholesale trading.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GTradeG1Wholesale TradingLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Pacific Bioengineering Private Limited FY 2024 filings available

Pacific Bioengineering Private Limited reported revenue of ₹4.51 Cr (down 22% YoY) for FY 2024.

Revenue · FY 2024
₹4.51 Cr ▼ 22%
Net profit · FY 2024
₹2.88 Lakh margin 0.6%
EBITDA · FY 2024
₹3.93 Lakh margin 0.9%

Compounded Annual Growth Rate (CAGR) of Pacific Bioengineering Private Limited

Revenue CAGR growth
1 year
▼ 22%
EBITDA CAGR growth
1 year
▼ 12%
3 years · compounded
▲ 56%
5 years · compounded
▲ 91%

Revenue fell 22% in the latest year. EBITDA fell 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Pacific Bioengineering Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹3.93 Lakh••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹2.88 Lakh••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Pacific Bioengineering Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin0.9%••••••••••••••••
Net Profit Margin0.6%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Pacific Bioengineering are in the company report.

Premium access

Financial statements from FY 2019

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Pacific Bioengineering Private Limited

Pacific Bioengineering Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Hychem Sainor Chemicals Private Limited₹4.53 Cr (FY 2024)••••••••-13.0%••••Hyderabad, Telangana, India
SGS Formulation Private Limited₹4.52 Cr (FY 2025)••••••••-21.0%••••Thiruvallur, Tamil Nadu, India
Medipaams India Private Limited₹4.52 Cr (FY 2024)••••••••13.0%••••Mumbai, Maharashtra, India
Lamet Pharma Private Limited₹4.52 Cr (FY 2022)••••••••-22.0%••••Thane, Maharashtra, India
Denizen Pharmaceuticals India Private Limited₹4.51 Cr (FY 2025)••••••••125.0%••••New Delhi, Delhi, India
Pacific Bioengineering Private Limited this company₹4.51 Cr (FY 2024)••••••••-22.0%••••Delhi, India
S N D Life Science Private Limited₹4.5 Cr (FY 2024)••••••••98.0%••••Navi Mumbai, Maharashtra, India
Astrazen Pharmaceuticals Private Limited₹4.5 Cr (FY 2025)••••••••4.0%••••Panchkula, Haryana, India
Nova Global Medicare Private Limited₹4.5 Cr (FY 2025)••••••••-4.0%••••Kolhapur, Maharashtra, India
S P M Drugs Private Limited₹4.49 Cr (FY 2025)••••••••-30.0%••••Erode, Tamil Nadu, India
Nice Pharmaceuticals Private Limited₹4.49 Cr (FY 2025)••••••••5.0%••••Delhi, India

Peers are the five companies nearest above and the five nearest below Pacific Bioengineering by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Pacific Bioengineering Private Limited

Pacific Bioengineering Private Limited is audited by BIKAS CHAND NATH for the financial year 2023.

NameStatusAppointment DateCessation Date
BIKAS CHAND NATHLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Pacific Bioengineering Private Limited

Pacific Bioengineering has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Vikash KumarDirector13 Dec 20187 Years 9 MonthsCurrent
Sanjib Kumar RoutDirector13 Dec 20187 Years 9 MonthsCurrent
View all directors

Ownership and Shareholding of Pacific Bioengineering Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Pacific Bioengineering Private Limited

Pacific Bioengineering Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Pacific Bioengineering Private Limited

Employment history and EPFO contributions of people linked to Pacific Bioengineering.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Pacific Bioengineering Private Limited

Pacific Bioengineering Private Limited has 3 board changes on record since 2018: 2 appointments and 1 cessation. The latest: Deven Manharlal Shah ceased to be Director on 02 Mar 2021.

AGM
Pacific Bioengineering Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Pacific Bioengineering Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Ceased
Deven Manharlal Shah ceased to be Director.
Appointed
Sanjib Kumar Rout was appointed as Director.
Appointed
Vikash Kumar was appointed as Director.
Incorporation
13 Dec 2018
Pacific Bioengineering Private Limited was registered on 13 Dec 2018 with Roc Delhi & aged 7 years 9 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Pacific Bioengineering Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Pacific Bioengineering Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Pacific Bioengineering Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Pacific Bioengineering Private Limited

Pacific Bioengineering has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
19AAKCP2473R1ZIWest BengalActive10 Jun 2021
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Pacific Bioengineering Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pacific Bioengineering Private Limited

Pacific Bioengineering is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 13 December 2018 (8+ years old) and is registered under CIN U74999DL2018PTC342991.

Pacific Bioengineering reported revenue of ₹4.51 Cr for FY 2024 (down 22% YoY).

Pacific Bioengineering has 2 current directors:

Pacific Bioengineering reported a net profit of ₹2.88 Lakh (net margin 0.6%) and EBITDA of ₹3.93 Lakh (EBITDA margin 0.9%) for FY 2024, as per its filed financial statements.

The GSTIN of Pacific Bioengineering is 19AAKCP2473R1ZI, registered in West Bengal. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Pacific Bioengineering is U74999DL2018PTC342991. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Pacific Bioengineering has 1 court case on record: 1 filed against it. 1 is pending.

Pacific Bioengineering was incorporated on 13 December 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Pacific Bioengineering by revenue are Hychem Sainor Chemicals Private Limited, SGS Formulation Private Limited, Medipaams India Private Limited, Lamet Pharma Private Limited, Denizen Pharmaceuticals India Private Limited and 5 more, all in the Pharma industry (Formulations).

Deven Manharlal Shah ceased to be Director on 02 Mar 2021. Sanjib Kumar Rout was appointed as Director on 13 Dec 2018. Vikash Kumar was appointed as Director on 13 Dec 2018.

The registered office of Pacific Bioengineering is at Unit No. 1 Ground Floor Wegmans Prinston Plaza Csc Sector – 18, Rohini, Delhi, India – 110085.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available